These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 926240

  • 1. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate.
    Fosså SD, Fosså J, Aakvaag A.
    J Urol; 1977 Dec; 118(6):1013-8. PubMed ID: 926240
    [Abstract] [Full Text] [Related]

  • 2. Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine.
    Bishop MC, Selby C, Taylor M.
    Br J Urol; 1985 Oct; 57(5):542-7. PubMed ID: 3904908
    [Abstract] [Full Text] [Related]

  • 3. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP, Wajsman Z, Kirdani RY, Murphy GP, Sandberg AA.
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [Abstract] [Full Text] [Related]

  • 4. Treatment of prostatic carcinoma with various types of estrogen derivatives.
    Jönsson G, Olsson AM, Luttrop W, Cekan Z, Purvis K, Diczfalusy E.
    Vitam Horm; 1975 Aug; 33():351-76. PubMed ID: 1229063
    [Abstract] [Full Text] [Related]

  • 5. Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Fritjofsson A, Norlén BJ, Högberg B, Rajalakshmi M, Cekan SZ, Diczfalusy E.
    Scand J Urol Nephrol; 1981 Aug; 15(1):37-44. PubMed ID: 6787701
    [Abstract] [Full Text] [Related]

  • 6. Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
    Sandberg AA, Rosenthal H, Mittelman A, Murphy GP.
    Urology; 1975 Jul; 6(1):17-21. PubMed ID: 1145919
    [Abstract] [Full Text] [Related]

  • 7. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
    Fosså SD, Miller A.
    J Urol; 1976 Apr; 115(4):406-8. PubMed ID: 1263316
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The oestrogenic effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate in patients with prostatic carcinoma. A comparative study of oestrogen sensitive liver proteins, gonadotrophins and prolactin.
    Daehlin L, Damber JE, von Schoultz B, Bergman B.
    Br J Urol; 1986 Aug; 58(4):412-6. PubMed ID: 3092893
    [Abstract] [Full Text] [Related]

  • 10. Effect of estramustine phosphate on plasma testosterone during treatment of carcinoma of prostate.
    Kjaer TB, Nilsson T, Madsen PO.
    Urology; 1975 Jun; 5(6):802-4. PubMed ID: 1136096
    [Abstract] [Full Text] [Related]

  • 11. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L, Edsmyr F, Jönsson G, Könyves I.
    Recent Results Cancer Res; 1977 Jun; (60):73-7. PubMed ID: 866798
    [Abstract] [Full Text] [Related]

  • 12. Estramustine phosphate: a specific chemotherapeutic agent?
    Von Hoff DD, Rozencweig M, Slavik M, Muggia FM.
    J Urol; 1977 Apr; 117(4):464-6. PubMed ID: 850319
    [Abstract] [Full Text] [Related]

  • 13. Clinical experimental randomized study of 2.6-cis-diphenylhexamethylcyclotetrasiloxane and estramustine-17-phosphate in the treatment of prostatic carcinoma.
    Edsmyr F, Esposti PL, Johansson B, Strindberg B.
    J Urol; 1978 Dec; 120(6):705-7. PubMed ID: 731810
    [Abstract] [Full Text] [Related]

  • 14. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
    Andersson L, Berlin T, Boman J, Collste L, Edsmyr F, Esposti PL, Gustafsson H, Hedlund PO, Hultgren L, Leander G, Nordle O, Norlén H, Tillegård P.
    Scand J Urol Nephrol Suppl; 1980 Dec; 55():143-5. PubMed ID: 6259722
    [Abstract] [Full Text] [Related]

  • 15. Estramustine phosphate in the treatment of advanced prostatic cancer.
    Küss R, Khoury S, Richard F, Fourcade F, Frantz P, Capelle JP.
    Br J Urol; 1980 Feb; 52(1):29-33. PubMed ID: 7426949
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM, Gow SM, Wu FC.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [Abstract] [Full Text] [Related]

  • 18. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
    Chisholm GD, O'Donoghue EP, Kennedy CL.
    Br J Urol; 1977 Jul; 49(7):717-20. PubMed ID: 339986
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of advanced carcinoma of the prostate with Estracyt (author's transl)].
    Nagel R, Kölln CP.
    Med Klin; 1976 Oct 08; 71(41):1724-8. PubMed ID: 824540
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.